JPH10231292A5 - - Google Patents

Info

Publication number
JPH10231292A5
JPH10231292A5 JP1997278908A JP27890897A JPH10231292A5 JP H10231292 A5 JPH10231292 A5 JP H10231292A5 JP 1997278908 A JP1997278908 A JP 1997278908A JP 27890897 A JP27890897 A JP 27890897A JP H10231292 A5 JPH10231292 A5 JP H10231292A5
Authority
JP
Japan
Prior art keywords
phenoxy
piperidinyl
hydroxyphenyl
hydroxynaphthalene
ethylamino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP1997278908A
Other languages
English (en)
Japanese (ja)
Other versions
JPH10231292A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JPH10231292A publication Critical patent/JPH10231292A/ja
Publication of JPH10231292A5 publication Critical patent/JPH10231292A5/ja
Withdrawn legal-status Critical Current

Links

JP9278908A 1996-10-10 1997-10-13 ２−アリール−３−アミノアリールオキシナフチル化合物、中間体、組成物及び方法 Withdrawn JPH10231292A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2844196P 1996-10-10 1996-10-10
US60/028441 1996-10-10

Publications (2)

Publication Number Publication Date
JPH10231292A JPH10231292A (ja) 1998-09-02
JPH10231292A5 true JPH10231292A5 (https=) 2005-06-16

Family

ID=21843469

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9278908A Withdrawn JPH10231292A (ja) 1996-10-10 1997-10-13 ２−アリール−３−アミノアリールオキシナフチル化合物、中間体、組成物及び方法

Country Status (8)

Country Link
EP (1) EP0835868B1 (https=)
JP (1) JPH10231292A (https=)
AT (1) ATE204868T1 (https=)
CA (1) CA2217810A1 (https=)
DE (1) DE69706386T2 (https=)
DK (1) DK0835868T3 (https=)
ES (1) ES2161417T3 (https=)
PT (1) PT835868E (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ID19392A (id) 1996-08-29 1998-07-09 Lilly Co Eli Senyawa naftil dan bahan pertengahan serta komposisi dan metode penggunaan
SI0826679T1 (en) * 1996-08-29 2002-04-30 Eli Lilly And Company Naphthyl compounds and compositions
AU7467398A (en) * 1997-04-25 1998-11-24 Eli Lilly And Company Indene compounds having activity as serms
EP1169043A1 (en) * 1999-01-18 2002-01-09 Novo Nordisk A/S Use of estrogens and delta-gonadien-21-ol-3,20-diones
KR20060109356A (ko) * 1999-08-03 2006-10-19 화이자 헬스 에이비 액체 분출 방법 및 액체 분출 장치
AU7896100A (en) * 1999-10-14 2001-04-23 Endorecherche Inc. Selective estrogen receptor modulators in the treatment or reduction of the riskof acquiring hypertension, cardiovascular diseases, and insulin resistance
JP2005504032A (ja) 2001-07-31 2005-02-10 ファイザー・プロダクツ・インク エストロゲン・アゴニスト／アンタゴニスト、エストロゲン及びプロゲスチンの組み合わせを含む医薬組成物、キット及び方法
EA008024B1 (ru) 2002-07-22 2007-02-27 Эли Лилли Энд Компани Селективные модуляторы эстрогенных рецепторов, содержащие фенилсульфонильную группу
PL377494A1 (pl) * 2003-02-25 2006-02-06 Eli Lilly And Company Krystaliczny, niesolwatowany chlorowodorek 1-(4-(2-pipe-rydynyloetoksy) fenoksy)-2-(4-metanosulfonylofenylo)-6- hydroksynaftalenu
KR100849559B1 (ko) * 2004-01-22 2008-07-31 일라이 릴리 앤드 캄파니 혈관운동 증상의 치료를 위한 선택적 에스트로겐 수용체조절제
CN1910167B (zh) * 2004-01-22 2011-08-10 伊莱利利公司 用于治疗血管舒缩症状的选择性雌激素受体调节剂
CA2571309A1 (en) 2004-06-22 2006-01-05 Smithkline Beecham Corporation Chemical compounds
FR2913017A1 (fr) * 2007-02-23 2008-08-29 Cerep Sa Derives de piperidine et piperazine comme agents anti-neoplasiques ou inhibiteurs de proliferation cellulaire
CN114133336B (zh) * 2020-09-03 2024-04-02 沈阳药科大学 4-甲氧基萘取代的苯胺类化合物及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5998401A (en) * 1995-02-28 1999-12-07 Eli Lilly And Company Naphthyl compounds, intermediates, compositions, and methods
US5811421A (en) * 1995-07-31 1998-09-22 Eli Lilly And Company Naphthyl and dihydronaphthyl intermediates, compounds, compositions, and methods

Similar Documents

Publication Publication Date Title
JPH10231292A5 (https=)
FI117373B (fi) Parasetamolia ja domperidonia sisältävä kalvopäällysteinen tabletti
US4929605A (en) Pharmaceutical composition for piperidinoalkanol derivatives
CN1125396A (zh) 阿司咪唑和假麻黄碱的缓释薄膜包衣片
US4159335A (en) Substituted anilino-2-thiazolines
TW467913B (en) Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione, maleic acid salt and its preparation
EP0022118A1 (fr) Nouveaux dérivés de sulfonyl-aniline, leur procédé de préparation et leur application en thérapeutique
US6514529B2 (en) Oxazolidinone tablet formulation
JPH1087577A5 (https=)
EP0310999B1 (en) Pharmaceutical composition for piperidinoalkanol derivatives
EP1265608B1 (en) Oxazolidinone tablet formulation
SK15472001A3 (sk) Použitie saredutantu a jeho farmaceuticky prijateľných solí na prípravu liečiva použiteľného na liečenie alebo prevenciu porúch nálady, porúch adaptácie alebo stavov úzkosti a depresie
CA2576067A1 (en) Diarylmethyl piperazine derivatives, preparations thereof and uses thereof
US20080234323A1 (en) Amorphous and Three Crystalline Forms of Rimonabant Hydrochloride
WO2023107980A1 (en) Solid state forms of an fgfr inhibitor
JPH1095778A5 (https=)
CA2077122A1 (en) Thiourea derivatives and antimicrobial agent and antiulcer agent containing the same
CA2455858A1 (en) Pharmaceutical preparations containing aminobenzene- sulfonic acid derivatives as the active ingredient
AU2001243243A1 (en) Oxazolidinone tablet formulation
CA1100511A (en) 3,5-disubstituted-1h-1,2,4-triazole derivatives
US3789125A (en) Pharmaceutical compositions containing halo-substituted 2-amino-benzylamine-amides
AU756338B2 (en) Stabile compositions comprising levosimendan and alginic acid
RU2001124835A (ru) Новые производные морфолина, способ их получения и содержащие их фармацевтические композиции
HUP0104514A2 (en) The use of aril-substituted cyclobutylalkylamines for treating urinary incontinence
US3846549A (en) Pharmaceutical compositions containing an n-(1-bicyclic aryl-propyl -2)-n-phenyl-piperazine